Author

P. Tiels

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:whole-genome sequencing· 2 Organism:bacteria (other)· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:genome assembly· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

E. Plets· 3 shared K. Borgers· 3 shared N. Callewaert· 3 shared N. Festjens· 3 shared A. Van Hecke· 2 shared G. Michielsen· 2 shared D. Vanderschaeghe· 1 shared E. Houthuys· 1 shared

Activity by Year

2018-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

E. Plets

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Exploration of synergistic action of cell wall-degrading enzymes against Mycobacterium tuberculosis

L. van Schie, K. Borgers, G. Michielsen, E. Plets, M. Vuylsteke, P. Tiels, N. Festjens, N. Callewaert

This study investigates the synergistic effects of cell wall-degrading enzymes against Mycobacterium tuberculosis using a novel microtiter assay and identifies potent enzyme combinations.

bioRxiv · Apr 5, 2021Microbiology

Reference genome for the WHO reference strain for Mycobacterium bovis BCG Danish, the present tuberculosis vaccine

K. Borgers, J.-Y. Ou, P.-X. Zheng, P. Tiels, A. Van Hecke, E. Plets, G. Michielsen, N. Festjens, N. Callewaert, Y.-C. Lin

The paper presents a completely assembled genome sequence of the WHO reference strain M. bovis BCG Danish 1331 using an integrated genome analysis workflow.

bioRxiv · Jan 7, 2019Microbiology

SapM mutation to improve the BCG vaccine: genomic, transcriptomic and preclinical safety characterization

N. Festjens, K. Vandewalle, E. Houthuys, E. Plets, D. Vanderschaeghe, K. Borgers, A. Van Hecke, P. Tiels, N. Callewaert

The paper characterizes a BCG vaccine mutant with a SapM mutation, showing improved safety and immune control, supporting its potential as a live attenuated TB vaccine.

bioRxiv · Dec 4, 2018Microbiology